Skip to main content

Table 3 Effect of pioglitazone and GW347845 in ZDF rats.

From: Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats

 

Insulin (ng/ml)

Glucose (mg/dL)

Triglycerides (mg/dL)

FFA (mEq/L)

Adiponectin (μg/ml)

ZDF lean rats

Vehicle

0.3 ± 0.1

158 ± 4

82 ± 7

0.31 ± 0.02

10.2 ± 0.5

ZDF rats

Vehicle

2.9 ± 0.5**

525 ± 25**

912 ± 97**

0.62 ± 0.03**

10.0 ± 1.1

Pioglitazone (mg/kg, B.I.D)

3

2.5 ± 0.6+

214 ± 64+

251 ± 81++

0.26 ± 0.09++

44.0 ± 7.7++

10

2.8 ± 0.5

154 ± 17++

129 ± 19++

0.16 ± 0.01++

60.0 ± 1.5++

30

2.3 ± 0.4+

154 ± 9++

129 ± 16++

0.14 ± 0.01++

63.0 ± 0.8++

GW347845 (mg/kg, B.I.D)

3

1.7 ± 0.2++

147 ± 6++

95 ± 10++

0.12 ± 0.01++

66.1 ± 0.6++

  1. **p < 0.01 vs ZDF lean rats. + p < 0.05 vs Vehicle-treated ZDF rats. ++p < 0.01 vs Vehicle-treated ZDF rats. N = 6–12 in each group.